Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model

Biomaterials

Volumn 33, Issue 10, 2012, Pages 2880-2891

  Zheng, Wenting ^a   Wang, Zhihong ^a   Song, Lijie ^a   Zhao, Qiang ^a   Zhang, Jun ^a   Li, Dong ^a   Wang, Shufang ^a   Han, Jihong ^a   Zheng, Xi Long ^c   Yang, Zhimou ^a   Kong, Deling ^a,b  

^a NANKAI UNIVERSITY   (China)

^b INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Endothelialization; RGD peptide; Smooth muscle regeneration; Surface modification; Vascular graft

Indexed keywords

ANTI-COAGULATION; ARGININE-GLYCINE-ASPARTIC ACIDS; CARDIO-VASCULAR DISEASE; CAROTID ARTERY; CELL INFILTRATION; ENDOTHELIALIZATION; FUNCTIONAL SURFACES; GROWING DEMAND; HEMOCOMPATIBILITY; HISTOLOGICAL ANALYSIS; HOMOGENEOUS DISTRIBUTION; IMMUNOFLUORESCENCE STAINING; INTEGRATION CAPABILITY; REVASCULARIZATION; RGD PEPTIDE; SMOOTH MUSCLE CELLS; SMOOTH MUSCLES; SURFACE AREA; THROMBUS FORMATION; TIME POINTS; VASCULAR GRAFTS;

AMINO ACIDS; BIODEGRADABLE POLYMERS; FUNCTIONAL POLYMERS; GRAFTS; MUSCLE; PLATELETS; SCANNING ELECTRON MICROSCOPY; SURFACE TREATMENT;

POLYCAPROLACTONE;

ARGINYLGLYCYLASPARTIC ACID; POLYCAPROLACTONE; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BLOOD COMPATIBILITY; BLOOD VESSEL GRAFT; CAROTID ARTERY; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; ELECTROSPINNING; ENDOTHELIUM CELL; FEMALE; HISTOLOGY; IMMUNOFLUORESCENCE; MATERIAL COATING; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RABBIT; REVASCULARIZATION; SCANNING ELECTRON MICROSCOPY; SMOOTH MUSCLE FIBER; SURFACE PROPERTY; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOGENESIS; VASCULAR PATENCY;

ANIMALS; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MUSCLE, SMOOTH; OLIGOPEPTIDES; PLATELET ADHESIVENESS; POLYESTERS; PROSTHESIS IMPLANTATION; RABBITS; REGENERATION; VASCULAR GRAFTING; VASCULAR PATENCY;

ORYCTOLAGUS CUNICULUS;

EID: 84862829375     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.12.047     Document Type: Article

References (47)

1. Canver C.C. Conduit options in coronary artery bypass surgery. Chest 1995, 108:1150-1155.
2. Zilla P., Bezuidenhout D., Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 2007, 28:5009-5027.
3. Lepidi S., Abatangelo G., Vindigni V., Deriu G.P., Zavan B., Tonello C., et al. Invivo regeneration of small-diameter (2 mm) arteries using a polymer scaffold. FASEB J 2006, 20:103-105.
4. Enomoto S., Sumi M., Kajimoto K., Nakazawa Y., Takahashi R., Takabayashi C., et al. Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material. JVasc Surg 2010, 51:155-164.
5. Hong Y., Ye S.H., Nieponice A., Soletti L., Vorp D.A., Wagner W.R. Asmall diameter, fibrous vascular conduit generated from a poly (ester urethane) urea and phospholipid polymer blend. Biomaterials 2009, 30:2457-2467.
6. Lovett M.L., Cannizzaro C.M., Vunjak-Novakovic G., Kaplan D.L. Gel spinning of silk tubes for tissue engineering. Biomaterials 2008, 29:4650-4657.
7. Wang S., Zhang Y., Wang H., Yin G., Dong Z. Fabrication and properties of the electrospun polylactide/silk fibroin-gelatin composite tubular scaffold. Biomacromolecules 2009, 10:2240-2244.
8. Kakisis J.D., Liapis C.D., Breuer C., Sumpio B.E. Artificial blood vessel: the holy grail of peripheral vascular surgery. JVasc Surg 2005, 41:349-354.
9. Brewster L.P., Bufallino D., Ucuzian A., Greisler H.P. Growing a living blood vessel: insights for the second hundred years. Biomaterials 2007, 28:5028-5032.
10. Place E.S., Evans N.D., Stevens M.M. Complexity in biomaterials for tissue engineering. Nat Mater 2009, 8:457-470.
11. Hashi C.K., Derugin N., Janairo R.R., Lee R., Schultz D., Lotz J., et al. Antithrombogenic modification of small-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol 2010, 30:1621-1627.
12. Woodruff M.A., Hutmacher D.W. The return of a forgotten polymer-polycaprolactone in the 21st century. Prog Polym Sci 2010, 35:1217-1256.
13. Pektok E., Nottelet B., Tille J.C., Gurny R., Kalangos A., Moeller M., et al. Degradation and healing characteristics of small-diameter poly(e{open}-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008, 118:2563-2570.
14. McClure M.J., Sell S.A., Simpson D.G., Walpoth B.H., Bowlin G.L. Athree-layered electrospun matrix to mimic native arterial architecture using polycaprolactone, elastin, and collagen: a preliminary study. Acta Biomater 2010, 6:2422-2433.
15. Ju Y.M., Choi J.S., Atala A., Yoo J.J., Lee S.J. Bilayered scaffold for engineering cellularized blood vessel. Biomaterials 2010, 31:4313-4321.
16. Xu F.J., Wang Z.H., Yang W.T. Surface functionalization of polycaprolactone films via surface-initiated atom transfer radical polymerization for covalently coupling cell-adhesive biomolecules. Biomaterials 2010, 31:3139-3147.
17. de Mel A., Jell G., Stevens M.M., Seifalian A.M. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 2008, 9:2969-2979.
18. Avci-Adali M., Ziemer G., Wendel H.P. Induction of EPC homing on biofunctionalized vascular grafts for rapid invivo self-endothelialization-a review of current strategies. Biotech Adv 2010, 28:119-129.
19. Tugulua S., Silaccib P., Stergiopulos N., Klok H.A. RGD-Functionalized polymer brushes as substrates for the integrin specific adhesion of human umbilical vein endothelial cells. Biomaterials 2007, 28:2536-2546.
20. Williams D.F. The role of short synthetic adhesion peptides in regenerative medicine; the debate. Biomaterials 2011, 32:4195-4197.
21. Gabriel M., van Nieuw Amerongen G.P., Van Hinsbergh V.W., Amerongen A.V., Zentner A. Direct grafting of RGD-motif-containing peptide on the surface of polycaprolactone films. JBiomater Sci Polym Ed 2006, 17:567-577.
22. Chung T.W., Yang M.G., Liu D.Z., Chen W.P., Pan C.I., Wang S.S. Enhancing growth human endothelial cells on Arg-Gly-Asp (RGD) embedded poly (e{open}-caprolactone) (PCL) surface with nanometer scale of surface disturbance. JBiomed Mater Res 2005, 72A:213-219.
23. Tambralli A., Blakeney B., Anderson J., Kushwaha M., Andukuri A., Dean D., et al. Ahybrid biomimetic scaffold composed of electrospun polycaprolactone nanofibers and self-assembled peptide amphiphile nanofibers. Biofabrication 2009, 1:025001.
24. Wang Z.H., Wang H.M., Zheng W.T., Zhang J., Zhao Q., Wang S.F., et al. Highly stable surface modifications of poly(e{open}-caprolactone) (PCL) films by molecular self-assembly to promote cells adhesion and proliferation. Chem Commun (Camb) 2011, 47:8901-8903.
25. Zhang M., Wang Z.X., Wang Z.F., Feng S.R., Xu H.J., Zhao Q., et al. Immobilization of anti-CD31 antibody on electrospun poly(e{open}-caprolactone) scaffolds through hydrophobins for specific adhesion of endothelial cells. Colloid Surf B 2010, 85:32-39.
26. Wang X.N., Chen C.Z., Yang M., Gu Y.J. Implantation of decellularized small-caliber vascular xenografts with and without surface heparin treatment. Artif Organs 2007, 31:99-104.
27. Zhu Y., Gao C., Liu X., Shen J. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules 2002, 3:1312-1319.
28. Harrington D.A., Cheng E.Y., Guler M.O., Lee L.K., Donovan J.L., Claussen R.C., et al. Branched peptide-amphiphiles as self-assembling coatings for tissue engineering scaffolds. JBiomed Mater Res 2006, 78A:157-167.
29. Meyers S.R., Kenan D.J., Khoo X., Grinstaff M.W. Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion. Biomacromoleces 2011, 12:533-539.
30. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
31. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
32. Tiwari A., Salacinski H.J., Punshon G., Hamilton G., Seifalian A.M. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J 2002, 16:791-796.
33. Tiwari A., Kidane A., Salacinski H., Punshon G., Hamilton G., Seifalian A.M. Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate. Eur J Vasc Endovasc Surg 2003, 25:325-329.
34. Patel S., Tsang J., Harbers G.M., Healy K.E., Li S. Regulation of endothelial cell function by GRGDSP peptide grafted on interpenetrating polymers. JBiomed Mater Sci 2007, 83A:423-433.
35. Ruoslahti E., Piersbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 1987, 238:491-497.
36. Joshi P., Chung C.Y., Aukhil I., Erickson H.P. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. JCell Sci 1993, 106:389-400.
37. Kim K.L., Han D.K., Park K., Song S.H., Kim J.Y., Kim J.M., et al. Enhanced dermal wound neovascularization by targeted delivery of endothelial progenitor cells using an RGD-g-PLLA scaffold. Biomaterials 2009, 30:3742-3748.
38. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
39. Blindt R., Vogt F., Astafieva I., Fach C., Hristov M., Krott N., et al. Anovel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. JAm Coll Cardiol 2006, 47:1786-1795.
40. Chan-Park M.B., Shen J.Y., Cao Y., Xiong Y., Liu Y., Rayatpisheh S., et al. Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. JBiomed Mater Sci 2009, 88A:1104-1121.
41. Tillman B.W., Yazdani S.K., Lee S.J., Geary R.L., Atala A., Yoo J.J. The invivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials 2009, 30:583-588.
42. Roha J.D., Sawh-Martinez R., Brennan M.P., Jay S.M., Devine L., Rao D.A., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci 2010, 107:4669-4674.
43. Tanaka K., Sata M., Hirata Y., Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 2003, 93:783-790.
44. Hu Y.H., Davison F., Ludewig B., Erdel M., Mayr M., Url M., et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:1834-1839.
45. Rodriguez-Menocal L., St-Pierre M., Wei Y.T., Khan S., Mateu D., Calfa M., et al. The origin of post-injury neointimal cells in the rat balloon injury model. Cardiovasc Res 2009, 81:46-53.
46. Hagensen M.K., Shim J., Falk E., Bentzon J.F. Flanking recipient vasculature, not circulating progenitor cells, contributes to endothelium and smooth muscle in murine allograft vasculopathy. Arterioscler Thromb Vasc Biol 2011, 31:808-813.
47. Rashid S.T., Salacinski H.J., Hamilton G., Seifalian A.M. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 2004, 25:1627-1637.